Latest News Archive

Please select Category, Year, and then Month to display items

UFS wins top awards at the 2024 Mace Excellence Awards

05 December 2024 | Story Dr Cindé Greyling | Photo Kaleidoscope

MACE Winners 2024 — From left to right: Burneline Kaars (Head: Employee Wellness and Organisational Development), Dr WP Wahl (Student Life Director), Linda Greyling (Senior Officer: Special Projects, Student Recruitment Services), Gerben Van Niekerk (Senior Officer: Kovsie Support Services), Malia Maranyane (Senior Officer: Undergraduate Marketing, Student Recruitment Services), Nomonde Mbadi (Student Recruitment Services Director), and Susan Van Jaarsveld (Senior Director: Human Resources).

On 28 November 2024, the University of the Free State (UFS) did it again – reigned as champions at the annual Marketing, Advancement and Communication in Education (MACE) Excellence Awards and walking away with two of the top awards: the MACE Award for Outstanding Research and the Severus Cerff Award for Consistent Excellence.

KovsieX was named the overall winner of the MACE Award for Outstanding Research. This award is made to the entry with the highest score in research, clearly demonstrating how research has supported the strategic objectives of the institution and the project. KovsieX is a multiplatform approach designed to leverage the strengths of diverse media channels. This digitalisation aligns with Vision 130, leveraging emerging technologies to enhance teaching and learning quality and efficiency of non-academic support structures and systems.

The UFS’ entries were of such high quality that the university won the sought-after Severus Cerff Award for Consistent Excellence. This award is based on the number of entries entered by an institution and the number and level of those entries winning awards. The award is therefore made to the institution with the highest success ratio.

Furthermore, the UFS Matriculant of the Year event received a Silver Award – entries scoring 5.75 or higher earn a Silver Award, placing this event among some of the top achievers in the events category. Three UFS entries received Gold Awards and were the winners in their respective categories: KovsieChat (Digital Channels), 2024 Women’s Day Breakfast (Events), and KovsieX (Stakeholder Engagement Campaigns). This is a magnificent achievement for the UFS.

"Winning a MACE award at this early stage is proof that KovsieX is not just meeting national standards – it’s setting them. If we can achieve this level of excellence now, imagine how we’ll compete on the global stage when the project is fully realised,” says Gerben van Niekerk, Student Media Manager.

Lacea Loader, Senior Director: Communication and Marketing and Coordinator of the MACE Excellence Awards, explained that a record number of entries were received for the Excellence Awards this year. “We are ecstatic about the direction of communication at the UFS and that the university has been able to maintain the quality of its entries in recent years,” says Loader.

The MACE Excellence Awards takes place annually as part of the MACE National Conference, recognising and celebrating excellence and the achievements of specialists and practitioners in marketing, advancement, and communication in the higher-education sector. This year, the Cape Peninsula University of Technology (CPUT) hosted the conference from 27 to 28 November 2024.

In 2023, the UFS won 11 awards, including the Chairperson’s Award of Excellence.

News Archive

HIV Cure – Just another fantasy?

2016-07-27

Dr Dominique Goedhals, Prof John Frater,
Dr Thabiso Mofokeng and Dr Jacob Jansen van Vuuren,
attended the lecture. Prof Frater has been working in
collaboration with the UFS Department of Internal
Medicine on HIV resistance and HIV immunology
since 2007.
Photo: Nonsindiso Qwabe

Twenty-years ago, after a person had been diagnosed with HIV, their lifespan did not exceed three years, but thanks to the success of antiretroviral therapy programmes, life expectancy has risen by an average of ten years. However, is antiretroviral therapy always going to be for life? This is the societal issue that Professor John Frater, addressed in his talk at the University of the Free State. He is an MRC Senior Clinical Fellow, Associate Professor and Honorary Consultant Physician in Infectious Diseases at Oxford University.

Antiretroviral medicine therapeutic

The discovery of antiretroviral therapy - the use of HIV medicines to treat the virus - has had a positive effect on the health and well-being of people living with it, improving their quality of life. Unfortunately, if treatment is stopped, HIV rebounds to the detriment of the patient. Now, research has shown that some patients, who are treated soon after being infected by HIV, may go off treatment for prolonged periods. Work is being done to predict who will be able to stop treatment.

“The difference made by starting treatment earlier is enormous. Delaying treatment is denying yourself the right to health,” Professor Frater says. However, this does not mean that the virus is cured. “A person can live for ten years without being on HIV treatment, but is that enough?” he went on to ask.

Healthy lifestyles encouraged

The National Department of Health will adopt a test and treat immediately strategy later this year to improve patient health and curb the spread of HIV. ,This is another reason why everybody should know their status and start treatment as soon as possible.

Search for a cure continues

More research is being conducted to establish whether HIV can be eradicated. Remission gives hope that a permanent cure may be found eventually. “Will a cure for HIV ever be found? Time will tell,” he concluded.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept